Embrella Cardiovascular Raises $5.1 Million
Embrella Cardiovascular, a Malvern, Penn.-based developer of a device for preventing dangerous debris from entering the brain during cardiovascular procedures, has raised $5.1 million in Series B funding. BioStar Ventures led the round, and was joined by Edwards Lifesciences Corp. and return backer MedFocus Fund.
10 June 2009•2 mins read
